News
Research and Markets: Abbott Laboratories Medical Equipment Company Share Analysis Report Provides an Analysis of Abbott's Key Revenue Lines
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets (http://www.researchandmarkets.com/research/af22b9/abbott_laboratorie) has announced the addition of the "Abbott Laboratories Medical Equipment Company Share Analysis" company profile to their offering.
This report is an essential source for data, analysis and strategic insight into Abbott Laboratories. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company’s business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company’s strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.
Scope
- Revenues for the markets and sub-sectors Abbott Laboratories operates in by country and region.
- Detailed breakdowns of revenues and market share benchmarked against competitors.
- Profiles of the pipeline of products that the company is developing.
- Critical analysis of the company’s strengths, weaknesses opportunities and threats and positioning on the value chain.
- Provides summary analysis of key revenue lines and strategy.
- Details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
- Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.
Reasons to buy
- A single source to fulfill all of your business and competitor intelligence needs
- Research your competitors business structure, strategy and prospects.
- Counter your competitors strengths and target their weaknesses.
- Identify your competitors key revenue streams by market and geography.
- Identify and assess potential corporate and investment opportunities
- Support sales activities by understanding your customers businesses better.
- Identify potential competitor products before they reach market.
- Qualify prospective partners and suppliers.
Key Topics Covered:
1 Executive Summary
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 19
2.1 What Is This Report About? 19
2.2 Definitions 19
2.2.1 Cardiovascular Devices 19
2.2.1.1 Interventional cardiology 19
2.2.1.2 Peripheral vascular devices 19
2.2.2 Patient monitoring 19
2.2.2.1 Micro- electromechanical systems (MEMS) 20
2.2.3 Diabetes Care Devices 20
2.2.3.1 Glucose Monitoring 20
2.2.4 In Vitro Diagnostics 20
2.2.4.1 Clinical Chemistry Test Reagents 20
2.2.4.2 Immunochemistry Test Reagents 20
2.2.4.3 Blood Test Reagents 20
2.2.4.4 Infectious Immunology Test Reagents 21
2.2.4.5 Genetic Test Reagents 21
2.2.4.6 Self Testing 21
3 Company Snapshot 22
3.1 Key Information 22
3.2 Company Overview 22
3.3 Financial Performance 22
3.4 Industry Outlook - Cardiovascular Devices 22
3.5 Industry Outlook - In Vitro Diagnostics 23
3.6 SWOT Snapshot 23
4 Business Description 24
4.1 Business Overview 24
4.2 Diagnostics 24
4.2.1 Overview 24
4.2.2 Financials 24
4.2.3 Market View 24
4.2.4 Key Strategies 24
4.3 Nutritionals 24
4.3.1 Overview 24
4.3.2 Financials 24
4.3.3 Market View 25
4.3.4 Key Strategies 25
4.4 Pharmaceuticals 25
4.4.1 Overview 25
4.4.2 Financials 25
4.4.3 Market View 25
4.4.4 Key Strategies 25
4.5 Vascular 25
4.5.1 Overview 25
4.5.2 Financials 26
4.5.3 Market View 26
4.5.4 Key Strategies 26
4.6 Major Products and Services 26
4.6.1 Overview 26
5 History 28
6 Business Strategy 32
6.1 Mission Statement 32
6.2 Strategy 32
6.3 Corporate Social Responsibility 32
6.3.1 Overview 32
6.3.2 Specific CSR Initiatives 32
7 Value Chain Analysis 33
7.1 Manufacturing 33
7.1.1 In House Manufacturing 33
7.2 Product Development 33
7.2.1 Regulatory Approvals 33
7.2.2 Clinical Trials 34
7.2.3 Research and Development 35
7.3 Sales and Marketing 35
7.3.1 Partnerships and Alliances 35
8 SWOT Analysis 36
8.1 Overview 36
8.2 Abbott Laboratories Strengths 36
8.2.1 Abbott Vascular 36
8.2.2 Strong R&D capability 36
8.2.3 Financial strength 37
8.3 Abbott Laboratories Weaknesses 37
8.3.1 Patent litigation 37
8.3.2 Relatively low operating margin 37
8.4 Abbott Laboratories Opportunities 37
8.4.1 Increasing therapeutic coverage of Humira 37
8.4.2 Acquisition of Kos Pharmaceuticals 38
8.4.3 Growing blood glucose testing market 38
8.5 Abbott Laboratories Threats 38
8.5.1 Environmental matters 38
8.5.2 Pending lawsuits 38
8.5.3 Industry consolidation 39
9 Competitors 40
10 Abbott Laboratories Medical Equipment Market Share Analysis 41
10.1 Abbott Laboratories, Global, Market Share (2007) 41
10.2 Abbott Laboratories, APAC, Market Share (2007) 43
10.3 Abbott Laboratories, Europe, Market Share (2007) 59
10.4 Abbott Laboratories, MEA, Market Share (2007) 101
10.5 Abbott Laboratories, North America, Market Share (2007) 111
10.6 Abbott Laboratories, SCA, Market Share (2007) 117
11 Abbott Laboratories Medical Equipment Market Share Analysis by Category 127
11.1 Abbott Laboratories, Global, Market Share (2007) 127
11.2 Abbott Laboratories, APAC, Market Share (2007) 129
11.3 Abbott Laboratories, Europe, Market Share (2007) 145
11.4 Abbott Laboratories, MEA, Market Share (2007) 187
11.5 Abbott Laboratories, North America, Market Share (2007) 197
11.6 Abbott Laboratories, SCA, Market Share (2007) 203
12 Revenue Analysis 213
12.1 Revenue by Segment 213
12.2 Revenue by Geography 213
13 Financial and Operational Review 215
13.1 Financial Statements 215
13.2 Financial Ratios 216
14 Share Holding Structure 217
15 Key Employees 218
16 Key Employee Biographies 219
17 Company Statement 220
18 Locations And Subsidiaries 223
18.1 Head Office 223
18.2 Other Locations & Subsidiaries 223
19 Financial Deals Landscape 225
19.1 Acquisition 225
19.1.1 Abbott Acquires Kos Pharmaceuticals 225
19.1.2 Abbott Acquires Spine Next 227
19.1.3 Chattem Acquires Selsun Blue 229
19.2 Venture Financing 230
19.2.1 Evalve Secures $60 Million In Series D Financing 230
19.2.2 3i and Other Investors Sell Spine Next To Abbott 232
19.3 Partnership 234
19.3.1 Luminex Enters Into A Partnership Agreement With Abbott 234
19.3.2 Abbott Laboratories Enters Into An Agreement With Enanta Pharmaceuticals 235
19.3.3 Abbott Laboratories Enters Into Distribution Agreement with Verax 237
19.3.4 AstraZeneca Signs An Agreement with Abbott 238
19.3.5 Abbott Laboratories Enters Into Licensing Agreement with Advanced Life Science 240
19.3.6 Abbott Enters Into An Agreement With Axis-Shield 241
19.3.7 Abbott Enters Into Licensing Agreement With Nephromics 243
19.3.8 Abbott Enters Into Licensing Agreement with BioCurex 244
19.3.9 Nihon Kohden And Abbott Laboratories Enter Into Commercialization Agreement 245
19.3.10 Abbott Signs An Agreement With OraSure 247
19.3.11 Abbott Enters Into Licensing Agreement With Cleveland Clinic 249
20 Recent Developments 251
21 Abbott Laboratories Pipeline Products 262
22 Appendix 268
List of Tables
List of Figures
The following companies are the major competitors of Abbott Laboratories:
Beckman Coulter, Inc.
Boston Scientific Corporation
Cordis Corporation
Dade Behring Holdings, Inc.
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Medtronic, Inc.
Ortho-Clinical Diagnostics Inc.
Siemens Medical Solutions
Edwards Lifesciences Corporation
For more information visit http://www.researchandmarkets.com/research/af22b9/abbott_laboratorie
Source: Global Markets Direct
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
